Control of Blood Glucose in Type 2 Diabetes by Modification of Conventional Diet Composition

Md. Taslim Hossain¹, Md. Nazibur Rahman² and Md. Mukter Hossain^3,

¹Youth Training Center, Department of Youth Development, Ministry of Youth and Sports, Bangladesh

²Department of Biochemistry and Molecularbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh

³Department of Medicine, Faculty of Veterinary, Animal and Biomedical Sciences, Sylhet Agricultural University, Sylhet 3100, Bangladesh

Cite this paper:
Md. Taslim Hossain, Md. Nazibur Rahman and Md. Mukter Hossain. Control of Blood Glucose in Type 2 Diabetes by Modification of Conventional Diet Composition. American Journal of Food and Nutrition. 2019; 7(3):72-77. doi: 10.12691/ajfn-7-3-1

Abstract

In this study, 100 clinically diagnosed types 2 diabetic patients were selected for investigation. The objective of this study was to control of blood glucose level in type 2 diabetic patient by the modification of conventional diet composition. The patients were studied using a randomized 5 week crossover design with the conventional and modified conventional diet (test diet) respectively. The mean body weight, BMI, waist circumference and waist to hip ratio were 60.1 ± 2.21 kg, 24.1 ± 2.71 kg/meter², 36.2 ± 0.762 inch and 0.904 ± 0.029 respectively with the conventional diet, that decreased to 59.5 ± 2.20 kg (P<0.01), 23.9 ± 2.73 kg/ meter² (P<0.05), 33.7 ± 0.512 inch (P<0.05) and 0.897 ± 0.026 (P<0.05) respectively after intervention of the test diet. The mean systolic and diastolic blood pressure were 124 ± 11.4 and 82 ± 6.9 mmHg respectively and after 5 weeks of intervention of test diet both the blood pressure decreased significantly (P<0.05) to 112 ± 8.6 and 69± 6.9 mmHg respectively. The mean fasting and postprandial blood sugar were 10.4 ± 0.38 and 12 ± 0.53 mmol/l with the conventional diet whereas it decreased significantly (P <0.001) to 8.1 ± 0.75 and 9.8 ± 0.40 mmol/l respectively. Before starting the test diet, the mean HbA1C was 6.4 ± 0.13 % but 5 week of post feeding the HbA1C decreased to 5.8 ± 0.19 % ( P<0.001). The mean ALT value was 47.5 ± 8.95 u/l and decreased significantly (P < 0.05) to 24.5 ± 4.19 u/l. During conventional diet, the mean AST and ALP level were 55.8 ± 25.18 and 93 ± 6.06 u/l respectively, after intervention it decreased to 42.8 ± 27.43 and 75 ± 10.85 u/l but not significantly (P = 0.759, P= 0.337).

Keywords:
blood glucose conventional diet modification diet type 2 diabetes

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Baruah, M.P., Kalra, S., Unnikrishnan, A.G., Raza, S.A., Somasundaram, N., John, M., Katulanda, P., Shrestha, D., Bantwal, G., Sahay, R., Latt, T.S. and Pathan, F.: Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines. Indian Journal of Endocrinology and Metabolism. 15: 75-90. 2011.
[2]	Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N.H., Cavan, D., Shaw, J.E. and Makaroff, L.E.: IDF diabetes atlas: global esti¬mates for the prevalence of diabetes for 2015 and 2040. Dia¬betes Research and Clinical Practice. 128: 40-50. 2017.
[3]	Klein, R., Knudtson, M.D., Lee, K.E., Gangnon, R. and Klein, B.E.: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty five year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 115: 1859-1868. 2008.
[4]	Fong, D.S., Aiello, L.P., Ferris, F.L. and Klein, R.: Diabetic retinopathy. Diabetes Care. 27: 2540-2553. 2004.
[5]	Gross, J.L., de Azevedo, M.J., Silveiro, S.P., Canani, L.H., Caramori, M.L. and Zelmanovitz, T.: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 28: 164-176. 2005.
[6]	Adler, A.I., Stevens, R.J., Manley, S.E., Bilous, R.W., Cull, C.A. and Holman, R.R.: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International. 63: 225-232. 2003.
[7]	Almdal, T., Scharling, H., Jensen, J.S. and Vestergaard, H.: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Archives of Internal Medecine. 164: 1422-1426. 2004.
[8]	Avogaro, A., Giorda, C., Maggini, M., Mannucci, E., Raschetti, R., Lombardo, F., Spila-Alegiani, S., Turco, S., Velussi, M. and Ferrannini, E.: Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care. 30: 1241-1247. 2007.
[9]	Li, D., Yeung, S.C., Hassan, M.M., Konopleva, M. and Abbruzzese, J.L.: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology. 137: 482-488. 2009.
[10]	Gannon, M.C., Hoover, H. and Nuttall FQ.: Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 weeks compared to 5 weeks in people with untreated type 2 diabetes. Nutrition and Metabolism (Lond). 7: 64. 2010.
[11]	Gannon, M.C. and Nuttall, F.Q.: Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 53: 2375-2382. 2004.
[12]	Garg, A., Bantle, J.P., Henry, R.R., Coulston, A.M., Griver, K.A., Raatz, S.K., Brinkley, L., Chen, Y.D., Grundy, S.M. and Huet, B.A.: Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. The Journal of the American Medical Association. 271: 1421-1428. 1994.
[13]	McFarlane, S.I., Shin, J.J., Rundek, T. and Bigger, J.T. Prevention of type 2 diabetes. Current Diabetes Reports. 3: 235-241. 2003.
[14]	Magos, L.: Modification of Evelyn and Malloy's method for the determination of methemoglobin. Industrial Medicine and Surgery. 29: 593. 1960.
[15]	Gannon, M.C., Nuttall, F.Q., Saeed, A., Jordan, K. and Hoover, H.: An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. The American Journal of Clinical Nutrition. 78: 734-741. 2003.
[16]	Nuttall, F.Q., Schweim, K., Hoover, H. and Gannon, M.C.: Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. British Journal of Nutrition. 99: 511-519. 2008.
[17]	Haimoto, H., Sasakabe, T., Wakai, K. and Umegaki, H.: Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes. Nutrition and Metabolism (Lond). 6: 21. 2009.
[18]	Sheard, N.F., Clark, N.G., Brand-Miller, J.C., Franz, M.J., Pi-Sunyer, F.X., Mayer-Davis, E., Kulkarni, K. and Geil, P.: Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American diabetes association. Diabetes Care. 27: 2266-2271. 2004.
[19]	Samaha, F.F., Iqbal, N., Seshadri, P., Chicano, K.L., Daily, D.A., McGrory, J., Williams, T., Williams, M., Gracely, E.J. and Stern, L. A low-carbohydrate as compared with a low-fat diet in severe obesity. New England Journal of Medicine. 348: 2074-2081. 2003.
[20]	Accurso, A., Bernstein, R.K., Dahlqvist, A., Draznin, B., Feinman, R.D., Fine, E.J. and Gleed, A.: Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutrition and Metabolism (Lond). 5: 9. 2008.
[21]	Feinman, R.D. and Fine, E.J.: Thermodynamics and Metabolic Advantage of Weight Loss Diets. Metab Synd Relat Disord 1: 209-219. 2003.
[22]	Krieger, J.W., Sitren, H.S., Daniels, M.J. and Langkamp-Henken, B.: Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression. American Journal of Clinical Nutrition. 83: 260-274. 2006.
[23]	Volek, J.S. and Feinman, R.D.: Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutrition and Metabolism (Lond). 2: 31. 2005.
[24]	Westman, E.C., Feinman, R.D., Mavropoulos, J.C., Vernon, M.C., Volek, J.S., Wortman, J.A., Yancy, W.S. and Phinney, S.D.: Low-carbohydrate nutrition and metabolism. American Journal of Clinical Nutrition. 86: 276-284. 2007.
[25]	Arora, S.K. and McFarlane, S.I.: The case for low carbohydrate diets in diabetes management. Nutrition and Metabolism (Lond). 2: 16. 2005.
[26]	Boden, G., Sargrad, K., Homko, C. and Mozzoli, M.: Effect of a Low -Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes. Annals of Internal Medicine. 142: 403-411. 2005.
[27]	Huang, K.C., Lin, W.Y., Lee, L.T., Chen, C.Y., Lo, H., Hsia, H.H., Liu, I.L., Shau, W.Y. and Lin, R.S.: Four anthropometric indices and cardiovascular risk factors in Taiwan. International Journal of Obesity and Related disorders. 26: 1060-1068. 2002.
[28]	Dalton, M., Cameron, A.J., Zimmet, P.Z., Shaw, J.E., Jolley, D., Dunstan, D.W. and Welborn, T.A.: Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. Journal of Internal Medicine. 254: 555-563. 2003.
[29]	Tulloch-Reid, M.K., Hanson, R.L., William, D.E., Knowler, W.C. and Looker, H.C.: Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care. 26: 2556-2561. 2003.
[30]	Okosun, I.S., Cooper, R.S., Rotini, C.N., Osotimehin, B. and Forrester, T.: Association of Waist Circumference with Risk of Hypertension and Type 2 Diabetes in Nigerians, Jamaicans, and African-Americans. Diabetes Care. 21: 1836-1842. 1998.
[31]	Tiikkainen, M., Bergholm, R., Vehkavaara, S., Rissanen, A., Hakkinen, A.M., Tamminen, M., Teramo, K. and Yki-Jarvinen, H.: Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes. 52: 701-707. 2003.
[32]	McFarlane, S.I., Banerji, M. and Sowers, J.R.: Insulin resistance and cardiovascular disease. The Journal of Clinical Endocrinology and Metabolism. 86: 713-718. 2001.
[33]	Dermot, N.: Liver enzymes, fatty liver and type 2 diabetes. Annals of Clinical Biochemistry. 42: 167-169. 2005.
[34]	Sato, K.K., Hayashi, T., Yoshiko, N., Harita, N., Yoneda, T., Endo, G. and Kambe, H.: Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes. Diabetes Care. 31: 1230-1236. 2008.
[35]	Nannipieri, M., Gonzales, C., Baldi, S., Posadas, R., Williams, K., Haffner, S.M., Stern, M.P. and Ferrannini, E.: Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City Diabetes Study. Diabetes Care. 28: 1757-1762. 2005.
[36]	Sattar, N., Scherbakova, O., Ford, I., O'Reilly, D.S., Stanley, A., Forrest, E., Macfarlane, P.W., Packard, C.J., Cobbe, S.M. and Shepherd, J.: Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland Coronary Prevention Study. Diabetes. 53: 2855-2860. 2004.
[37]	Vozarova, B., Stefan, N., Lindsay, R.S., Saremi, A., Pratley, R.E., Bogardus, C. and Tataranni, P.A.: High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 51: 1889-1895. 2002.
[38]	Cho, N.H., Jang, H.C., Choi, S.H., Kim, H.R., Lee, H.K., Chan, J.C.N. and Lim, S.: Abnormal Liver Function Test Predicts Type 2 Diabetes. Diabetes Care. 30: 2566-2568. 2007.